VOLPI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 25.818
EU - Europa 12.826
AS - Asia 3.432
SA - Sud America 170
AF - Africa 64
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 32
Totale 42.386
Nazione #
US - Stati Uniti d'America 25.696
GB - Regno Unito 5.195
IT - Italia 2.317
SE - Svezia 1.565
CN - Cina 1.316
UA - Ucraina 935
DE - Germania 918
TR - Turchia 786
HK - Hong Kong 622
FI - Finlandia 470
BG - Bulgaria 384
FR - Francia 291
KR - Corea 153
IN - India 119
ES - Italia 99
VN - Vietnam 94
RU - Federazione Russa 86
BR - Brasile 79
CH - Svizzera 77
IE - Irlanda 77
PL - Polonia 72
CA - Canada 67
JP - Giappone 57
IR - Iran 48
MX - Messico 46
NL - Olanda 46
AU - Australia 40
MY - Malesia 40
TH - Thailandia 40
GR - Grecia 37
BE - Belgio 36
RO - Romania 33
SG - Singapore 32
AR - Argentina 30
LT - Lituania 29
ID - Indonesia 27
PT - Portogallo 27
CZ - Repubblica Ceca 26
RS - Serbia 26
EU - Europa 25
PK - Pakistan 24
PE - Perù 21
PH - Filippine 17
TN - Tunisia 17
CL - Cile 16
EG - Egitto 14
CO - Colombia 13
DK - Danimarca 12
DZ - Algeria 12
SI - Slovenia 12
NO - Norvegia 11
TW - Taiwan 10
HR - Croazia 8
IL - Israele 8
ZA - Sudafrica 8
EC - Ecuador 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AT - Austria 6
HU - Ungheria 6
MA - Marocco 6
UZ - Uzbekistan 6
AL - Albania 5
MO - Macao, regione amministrativa speciale della Cina 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
CU - Cuba 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
JO - Giordania 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SM - San Marino 3
UG - Uganda 3
BD - Bangladesh 2
BY - Bielorussia 2
CR - Costa Rica 2
LB - Libano 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
OM - Oman 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 42.386
Città #
Southend 4.419
Fairfield 3.402
Woodbridge 2.606
Chandler 2.100
Houston 2.048
Ashburn 2.026
Jacksonville 1.993
Dearborn 1.557
Seattle 1.206
Wilmington 1.188
Ann Arbor 1.185
Cambridge 1.101
Nyköping 950
Hong Kong 615
Beijing 577
Modena 423
Princeton 414
Sofia 369
Izmir 363
Eugene 356
San Diego 329
New York 283
Redwood City 220
Helsinki 157
Milan 150
London 137
Des Moines 123
Rome 86
Falls Church 84
Dong Ket 80
Dublin 62
Norwalk 60
Hefei 59
Bologna 52
Nanjing 50
Boardman 49
Istanbul 46
Madrid 45
Shanghai 43
Kunming 40
Naples 36
Jinan 34
Toronto 34
Kilburn 32
Verona 31
Brussels 28
Seoul 28
Nanchang 27
Florence 26
Bangkok 24
Belgrade 24
Chiswick 24
Hounslow 23
Fremont 22
Parma 22
Turin 21
Frankfurt am Main 19
Guangzhou 19
Los Angeles 19
Perugia 19
San Mateo 19
Auburn Hills 18
Indiana 18
Kraków 18
Mountain View 18
Philadelphia 18
Saint Petersburg 18
Paris 17
Stockholm 17
Zhengzhou 17
Athens 16
Chongqing 16
Monterrey 16
Prescot 16
San Francisco 16
Atlanta 15
Barcelona 15
Caserta 15
Dongguan 15
Ottawa 15
Padova 15
San Giuliano Milanese 15
Seongnam-si 15
Torino 15
Amsterdam 14
Ankara 14
Chicago 14
Phoenix 14
Poznan 14
Bristol 13
Orange 13
Tokyo 13
Bremen 12
Duncan 12
Palermo 12
Washington 12
Bari 11
Brescia 11
Dallas 11
Glasgow 11
Totale 32.159
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 613
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 467
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 417
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 373
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 298
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 265
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 257
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 243
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 221
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 216
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 212
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 210
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 209
A 96-well assay for uronic acid carbazole reaction 206
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 203
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 200
Isolation and structural characterization of chondroitin sulfate from bony fishes 194
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 193
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 191
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 190
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 188
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 181
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 177
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 177
Recent advances on separation and characterization of human milk oligosaccharides. 177
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 174
Electrophoresis for the analysis of heparin purity and quality. 172
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 172
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 171
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 171
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 171
Capillary electrophoresis of bacterial (lipo)polysaccharides 170
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 170
I glicosaminoglicani: struttura, funzioni, tecniche analitiche di indagine, e loro modificazioni in valvole mitraliche ed aortiche di soggetti affetti da patologia degenerativa 169
Composition and structure elucidation of human milk glycosaminoglycans 168
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 167
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 167
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 167
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 167
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 166
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 163
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 163
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 161
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 159
Human milk glycosaminoglycans: the state of the art and future perspectives 158
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 157
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 156
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 156
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 155
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 155
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 154
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 154
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 153
Electrophoretic approaches to the analysis of complex polysaccharides 152
Glycosaminoglycan content in term and preterm milk during the first month of lactation 152
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 152
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 151
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 150
Comparative analysis of fatty acid profile in three eutardigrade species 150
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 149
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone 149
Stability studies of chondroitin sulfate 149
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 148
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 148
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 148
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 147
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 146
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 146
Effect of nonanimal high- and low-molecular-mass chondroitin sulfates produced by a biotechnological process in an animal model of polyarthritis 146
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 146
Effect of holder pasteurisation on human milk glycosaminoglycans 146
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 145
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 145
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 145
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 145
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role 145
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 145
Analytical aspects of pharmaceutical grade chondroitin sulfates 145
Regulation of arylsulphatases: inhibition of arylsulphatase from Haliotis rufusensis by phosphoric esters and shift of optimal pH depending on temperature 143
Recenti approcci analitici per la valutazione della qualità della propoli 143
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 143
Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea 143
Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: Influence of position of sulfate groups and charge density 143
Anti-zika virus and anti-usutu virus activity of human milk and its components 143
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 142
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 142
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 142
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus. 142
Hyaluronan in medical practice 142
Effect of low-frequency electromagnetic pulsed field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 141
Different analyses measure chondroitin pharmacokinetics. 141
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 140
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 140
Chondroitin Sulfate Effect On Induced Arthritis In Rats 140
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 140
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 139
Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography 139
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease 139
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 139
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 138
Totale 17.658
Categoria #
all - tutte 155.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.291 0 0 0 0 0 0 0 0 0 0 1.244 1.047
2019/20209.143 616 639 325 595 1.113 1.363 1.369 1.108 729 379 554 353
2020/20217.428 1.145 230 492 506 675 825 663 880 358 843 434 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.056 227 281 197 571 1.042 351 394 584 128 134 147 0
Totale 42.807